Detalles de la búsqueda
1.
A SARS-CoV-2 serological assay to determine the presence of blocking antibodies that compete for human ACE2 binding
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20114652
2.
Engineering luminescent biosensors for point-of-care SARS-CoV-2 antibody detection
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-20176925
3.
Bi-paratopic and multivalent human VH domains neutralize SARS-CoV-2 by targeting distinct epitopes within the ACE2 binding interface of Spike
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-242511
4.
Engineered ACE2 receptor traps potently neutralize SARS-CoV-2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-231746
5.
Trimeric SARS-CoV-2 Spike interacts with dimeric ACE2 with limited intra-Spike avidity
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-109157
6.
BRD2 inhibition blocks SARS-CoV-2 infection in vitro by reducing transcription of the host cell receptor ACE2
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-427194
7.
Computational pipeline provides mechanistic understanding of Omicron variant of concern neutralizing engineered ACE2 receptor traps
Preprint
en Inglés
| PREPRINT-BIORXIV | ID: ppbiorxiv-503400
8.
SARS-CoV-2 antibody magnitude and detectability are driven by disease severity, timing, and assay
Preprint
en Inglés
| PREPRINT-MEDRXIV | ID: ppmedrxiv-21251639
Resultados
1 -
8
de 8
1
Próxima >
>>